Researchers Report Lab Results Showing Enzymes Important in Myelin Repair
July 27, 2018
Currently, there are no approved medications that can promote myelin repair in the brain. Researchers at Case Western Reserve University have demonstrated that miconazole – a drug used to treat athlete’s foot – enhanced myelin formation by inhibiting an enzyme used to produce cholesterol. Further experiments showed that more than 20 new drugs that enhance myelin formation inhibit similar enzymes.
These interesting findings are still in early stages, and no conclusions can be drawn about what they mean for the use of miconazole or inhibiting cholesterol as a safe, effective strategy for MS. According to a press release from the university, experimental treatments based on this work are not expected to enter human trials until 2019.
The Society is currently funding one author of this study, Paul Tesar, PhD, to investigate the underlying factors that hinder stem cells in the brain from replacing myelin in people with MS.
Read more from Case Western University
Read a scientific summary of this study
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.
The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, X, formerly known as Twitter, Instagram, YouTube or 1-800-344-4867.